Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fulcrum Therapeutics

6.88
+0.28004.24%
Post-market: 6.880.00000.00%16:21 EDT
Volume:1.04M
Turnover:7.13M
Market Cap:371.38M
PE:-837.90
High:7.06
Open:6.69
Low:6.31
Close:6.60
Loading ...
Jun 24, 2021

Major Issues Report

8-K - Current report
Jun 11, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

Major Issues Report

8-K - Current report
Mar 04, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 04, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 20, 2021

Major Issues Report

8-K - Current report
Jan 19, 2021

Major Issues Report

8-K - Current report
Nov 13, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2020

Major Issues Report

8-K - Current report
Sep 18, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 13, 2020

Correspondence

CORRESP [Cover] - Correspondence